Medicament for inhibiting cancer cells without harmful effect to normal cells

The present invention relates to a pharmaceutical composition and a method for treating cancer, especially relates to a pharmaceutical composition including curative dose plant extract and pharmaceutically acceptable carrier and a method for treating cancer by using same.

Saved in:
Bibliographic Details
Main Authors CHEN LEZONG, CHEN HAO, ZHANG JIETING, ZHAO WENCHAO, LIN XIAOLI, LI MING, CHENG LEI
Format Patent
LanguageChinese
English
Published 27.01.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to a pharmaceutical composition and a method for treating cancer, especially relates to a pharmaceutical composition including curative dose plant extract and pharmaceutically acceptable carrier and a method for treating cancer by using same.
AbstractList The present invention relates to a pharmaceutical composition and a method for treating cancer, especially relates to a pharmaceutical composition including curative dose plant extract and pharmaceutically acceptable carrier and a method for treating cancer by using same.
Author CHENG LEI
CHEN LEZONG
ZHAO WENCHAO
LIN XIAOLI
LI MING
ZHANG JIETING
CHEN HAO
Author_xml – fullname: CHEN LEZONG
– fullname: CHEN HAO
– fullname: ZHANG JIETING
– fullname: ZHAO WENCHAO
– fullname: LIN XIAOLI
– fullname: LI MING
– fullname: CHENG LEI
BookMark eNqNyjsOwjAMANAMMPC7gzkAEiUCZlSBWMrEXpngEEuJUyWuuD4DHIDpLW9uJpKFZqbr6MkOE4mCzwVYAj9YWV7gUBwVcBRjhTdryKNCwJL8GIG8J6egGSSXhPHblmbqMVZa_VyY9eV8b68bGnJPdUBHQtq3t2bbHOzuaPcn-8_5ABBUN_s
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN101632735A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN101632735A3
IEDL.DBID EVB
IngestDate Fri Jul 19 16:00:09 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN101632735A3
Notes Application Number: CN200910005243
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100127&DB=EPODOC&CC=CN&NR=101632735A
ParticipantIDs epo_espacenet_CN101632735A
PublicationCentury 2000
PublicationDate 20100127
PublicationDateYYYYMMDD 2010-01-27
PublicationDate_xml – month: 01
  year: 2010
  text: 20100127
  day: 27
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies THE CHINESE UNIVERSITY OF HONG KONG
RelatedCompanies_xml – name: THE CHINESE UNIVERSITY OF HONG KONG
Score 2.8261487
Snippet The present invention relates to a pharmaceutical composition and a method for treating cancer, especially relates to a pharmaceutical composition including...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title Medicament for inhibiting cancer cells without harmful effect to normal cells
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100127&DB=EPODOC&locale=&CC=CN&NR=101632735A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwjSt6Jt0q-HIi5tGUK7IVP2NpquYR2jHVuH4F9v0nbOF30LSTiSC5fL3f3uAvBgmtwxLc7URIstYaA4XGV27KhPU2NqxCnmTipzh8PI7L-T17ExbsF8mwtT1Qn9rIojColKhLyX1X293DmxvApbuX5kmegqnoOR6ymNdaxVkVTF67n-cOANqEKpSyMlenOlkYqFqjZe9mBfN7Ap4V_-R09mpSx_q5TgBA6GglpenkLra9aBI7r9ea0Dh2ET8BbNRvbWZxDWMRXpzUPipYmyfJaxTKKWUSKPboWkE36NpGe12JRI1qTmmwWqERuoLFAu36eLeto53Af-iPZVsa7JDxMmNNptAV9AOy_y9BIQtkiMHaZNCXeIlTBbj3WuE5PbNicEsyvo_k2n-9_gNRzXkXJN1a0baJerTXorFHDJ7irOfQPSXItz
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3JTsJA9AXRiDdFjeI2JtqTjXRvD42RFgJCCzFovJFO2wlNSEtoidEP8judaYt4UeNtMvv25u1vAK5UlRiqRjDvC55GGRSD8Fj3DL4ZKIHihRIxQuY77Lhq90l-eFFeKvCx8oXJ44S-5sERKUT5FN6z_L2er4VYdm5bmd7iiGYld52xaXMldyzkmlTObpnt0dAeWpxlmZbLuY8mY1IliqqV-9Lpox--0bGC1OzZ9C5ci2KnPba6PKV6J18jTyx33U6idTZgk8Jjk5mOtZ9bzKNl_h0ddXZha0RnEmd7UHmf1qFmrX5tq8O2UyrLabKE23QfnEIfwySBiFKpKIqnEY6YxTPy2bEvEBPgp4hJZZNlhlg8a7KcocLaA2UJihltOyuqHcDln8s4hGqcxOERIEmTPcnAQiATQ9Z8rIueSERZJbpOZFnCx9D4uZ_Gb4UXUOuOncFk0HP7J7BTaNwFXtROoZotluEZReQZPs93EcHNf47gE-uyrco
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Medicament+for+inhibiting+cancer+cells+without+harmful+effect+to+normal+cells&rft.inventor=CHEN+LEZONG&rft.inventor=CHEN+HAO&rft.inventor=ZHANG+JIETING&rft.inventor=ZHAO+WENCHAO&rft.inventor=LIN+XIAOLI&rft.inventor=LI+MING&rft.inventor=CHENG+LEI&rft.date=2010-01-27&rft.externalDBID=A&rft.externalDocID=CN101632735A